Picibanil (OK-432) in the treatment of head and neck lymphangiomas in children

• Main Authors: Elena Rebuffini (Author), Luca Zuccarino (Author), Emma Grecchi (Author), Francesco Carinci (Author), Vittorio Emanuele Merulla (Author)
• 格式: 圖書
• 出版: Wolters Kluwer Medknow Publications, 2012-01-01T00:00:00Z.
• 主題: article
• 在線閱讀: Connect to this object online.

Background: Picibanil (OK-432) is a lyophilized mixture of group A Streptococcus pyogenes with antineoplastic activity. Because of its capacity to produce a selective fibrosis of lymphangiomas (LMs), it has been approved by Japanese administration in 1995 for the treatment of LMs. Materials and Meth...